With a robust background in private equity, the fund manager has executed over 20 deals primarily in the technology and healthcare sectors, demonstrating a keen ability to identify high-potential opportunities. Active in both North American and European markets, their strategic style emphasizes a data-driven approach that supports operator-first investment decisions. Recent notable exits include successful transitions in the biotech and software domains, showcasing a commitment to nurturing portfolio companies through various growth stages. This experience underscores a versatile investment philosophy focused on thematic trends and long-term value creation.